ACE2 and COVID-19: The activation of the RAS axis due to the binding of SARS-CoV-2 to ACE2, which leads to the direct loss of ACE2 and indirect loss of ACE2 via proteolytic processing and shedding, partly drives the systemic manifestations of COVID-19.